Hepatocellular Carcinoma: Consensus Recommendations of the National Cancer Institute Clinical Trials Planning Meeting

Survival of patients with hepatocellular carcinoma in cirrhosis: a comparison of BCLC, CLIP and GRETCH staging systems

(2010) C. CAMMÀ et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

The American Joint Committee on Cancer: the 7th Edition of the AJCC Cancer Staging Manual and the Future of TNM

(2010) Stephen B. Edge et al.   ANNALS OF SURGICAL ONCOLOGY

Epidemiology of hepatitis B in the United States

(2010) W. Ray Kim   HEPATOLOGY

Management of advanced hepatocellular carcinoma in the era of targeted therapy

(2010) Thomas Yau et al.   LIVER INTERNATIONAL

Impact of evidence-based medicine on the treatment of patients with unresectable hepatocellular carcinoma

(2009) E. G. GIANNINI et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Rocks Along the Road to the Control of HBV and HCC

(2009) R. Palmer Beasley   ANNALS OF EPIDEMIOLOGY

Prognostic Significance of the DNA-Index in Liver Transplantation for Hepatocellular Carcinoma in Cirrhosis

(2009) Sven Jonas et al.   ANNALS OF SURGERY

Management of Early Hepatocellular Carcinoma in Patients with Well-Compensated Cirrhosis

(2009) Steven C. Cunningham et al.   ANNALS OF SURGICAL ONCOLOGY

Transcriptomic profiling identifies a PU.1 regulatory network in macrophages

(2009) Karin Weigelt et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Prognostic role of vascular endothelial growth factor in hepatocellular carcinoma: systematic review and meta-analysis

(2009) S J Schoenleber et al.   BRITISH JOURNAL OF CANCER

A comparison of outcomes from treating hepatocellular carcinoma by hepatic artery embolization in patients younger or older than 70 years

(2009) Raymond H. Thornton et al.   CANCER

Metabolic syndrome and hepatocellular carcinoma

(2009) Abby B. Siegel et al.   CANCER

Annual report to the nation on the status of cancer, 1975-2006, featuring colorectal cancer trends and impact of interventions (risk factors, screening, and treatment) to reduce future rates

(2009) Brenda K. Edwards et al.   CANCER

(-)-Epigallocatechin gallate suppresses the growth of human hepatocellular carcinoma cells by inhibiting activation of the vascular endothelial growth factor-vascular endothelial growth factor receptor axis

(2009) Yohei Shirakami et al.   CANCER SCIENCE

Prospective Randomized Comparison of Chemoembolization with Doxorubicin-Eluting Beads and Bland Embolization with BeadBlock for Hepatocellular Carcinoma

(2009) Katerina Malagari et al.   CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY

NASH and HCC

(2009) John M. Page et al.   Clinics in Liver Disease

Hepatocellular Carcinoma – Epidemiological Trends and Risk Factors

(2009) Kerstin Schütte et al.   DIGESTIVE DISEASES

Factors Associated with Progression to Hepatocellular Carcinoma and to Death from Liver Complications in Patients with HBsAg-Positive Cirrhosis

(2009) Myron John Tong et al.   DIGESTIVE DISEASES AND SCIENCES

Percutaneous radiofrequency ablation of hepatocellular carcinoma abutting the diaphragm and gastrointestinal tracts with the use of artificial ascites: safety and technical efficacy in 143 patients

(2009) Inyoung Song et al.   EUROPEAN RADIOLOGY

mTOR inhibitors for hepatocellular cancer: a forward-moving target

(2009) Gerhard Treiber   Expert Review of Anticancer Therapy

Targeting angiogenesis in hepatocellular carcinoma: focus on VEGF and bevacizumab

(2009) Richard S Finn et al.   Expert Review of Anticancer Therapy

High expressions of vascular endothelial growth factor and platelet-derived endothelial cell growth factor predict poor prognosis in alpha-fetoprotein-negative hepatocellular carcinoma patients after curative resection

(2009) Jie Hu et al.   JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY

Phase II Trial of the Combination of Bevacizumab and Erlotinib in Patients Who Have Advanced Hepatocellular Carcinoma

(2009) Melanie B. Thomas et al.   JOURNAL OF CLINICAL ONCOLOGY

Efficacy, Safety, and Potential Biomarkers of Sunitinib Monotherapy in Advanced Hepatocellular Carcinoma: A Phase II Study

(2009) Andrew X. Zhu et al.   JOURNAL OF CLINICAL ONCOLOGY

Revised Tumor and Node Categorization for Rectal Cancer Based on Surveillance, Epidemiology, and End Results and Rectal Pooled Analysis Outcomes

(2009) Leonard L. Gunderson et al.   JOURNAL OF CLINICAL ONCOLOGY

AZD6244 enhances the anti-tumor activity of sorafenib in ectopic and orthotopic models of human hepatocellular carcinoma (HCC)

(2009) Hung Huynh et al.   JOURNAL OF HEPATOLOGY

Decreased Incidence of Hepatocellular Carcinoma in Hepatitis B Vaccinees: A 20-Year Follow-up Study

(2009) Mei-Hwei Chang et al.   JNCI-Journal of the National Cancer Institute

Safety and efficacy of sunitinib in patients with advanced hepatocellular carcinoma: an open-label, multicentre, phase II study

(2009) Sandrine Faivre et al.   LANCET ONCOLOGY

Recurrence of hepatocellular carcinoma and hepatitis B reinfection in hepatitis B surface antigen-positive patients after liver transplantation

(2009) Sammy Saab et al.   LIVER TRANSPLANTATION

Sorafenib for the Treatment of Unresectable Hepatocellular Carcinoma

(2009) R. C. Kane et al.   ONCOLOGIST

Major hepatic resection for hepatocellular carcinoma with or without portal vein embolization: Perioperative outcome and survival

(2009) Martin Palavecino et al.   SURGERY

Review article: pharmacological therapy for hepatocellular carcinoma with sorafenib and other oral agents

(2008) M. CHAPARRO et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Prognosis of advanced hepatocellular carcinoma: comparison of three staging systems in two French clinical trials

(2008) S. Collette et al.   ANNALS OF ONCOLOGY

Treatment before Liver Transplantation for HCC

(2008) J. Belghiti et al.   ANNALS OF SURGICAL ONCOLOGY

Bridging Locoregional Therapy for Hepatocellular Carcinoma Prior to Liver Transplantation

(2008) Jason T. Heckman et al.   ANNALS OF SURGICAL ONCOLOGY

Recurrence of Hepatocellular Carcinoma Following Liver Transplantation

(2008) Michael A. Zimmerman   ARCHIVES OF SURGERY

Liver cancer: Descriptive epidemiology and risk factors other than HBV and HCV infection

(2008) Shu-Chun Chuang et al.   CANCER LETTERS

Gene expression profiling in colorectal cancer using microarray technologies: Results and perspectives

(2008) Margherita Nannini et al.   CANCER TREATMENT REVIEWS

Bridge Treatments of Hepatocellular Carcinoma in Cirrhotic Patients Submitted to Liver Transplantation

(2008) Maurizio Pompili et al.   DIGESTIVE DISEASES AND SCIENCES

New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)

(2008) E.A. Eisenhauer et al.   EUROPEAN JOURNAL OF CANCER

Detection of hypervascular malignant foci in borderline lesions of hepatocellular carcinoma: comparison of dynamic multi-detector row CT, dynamic MR imaging and superparamagnetic iron oxide-enhanced MR imaging

(2008) Rieko Shinmura et al.   EUROPEAN RADIOLOGY

TACE versus TAE as therapy for hepatocellular carcinoma

(2008) Maria Pleguezuelo et al.   Expert Review of Anticancer Therapy

Early development of sunitinib in hepatocellular carcinoma

(2008) Andrew X Zhu et al.   Expert Review of Anticancer Therapy

Pivotal Role of mTOR Signaling in Hepatocellular Carcinoma

(2008) Augusto Villanueva et al.   GASTROENTEROLOGY

Diabetes mellitus, chronic hepatitis C, and hepatocellular carcinoma

(2008) Yan-Dan Zhong et al.   HEPATOLOGY

Combination Targeted Therapy With Sorafenib and Bevacizumab Results in Enhanced Toxicity and Antitumor Activity

(2008) Nilofer S. Azad et al.   JOURNAL OF CLINICAL ONCOLOGY

Phase II Trial Evaluating the Clinical and Biologic Effects of Bevacizumab in Unresectable Hepatocellular Carcinoma

(2008) Abby B. Siegel et al.   JOURNAL OF CLINICAL ONCOLOGY

Detection of Hypervascular Hepatocellular Carcinoma With Multidetector-Row CT

(2008) Takatoshi Kitamura et al.   JOURNAL OF COMPUTER ASSISTED TOMOGRAPHY

Comparison of four current staging systems for Chinese patients with hepatocellular carcinoma undergoing curative resection: Okuda, CLIP, TNM and CUPI

(2008) Wenping Lu et al.   JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY

Bevacizumab and rapamycin induce growth suppression in mouse models of hepatocellular carcinoma

(2008) Hung Huynh et al.   JOURNAL OF HEPATOLOGY

Correlations of the expression of vascular endothelial growth factor B and its isoforms in hepatocellular carcinoma with clinico-pathological parameters

(2008) Mitsuro Kanda et al.   JOURNAL OF SURGICAL ONCOLOGY

Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial

(2008) Ann-Lii Cheng et al.   LANCET ONCOLOGY

Expanded criteria for liver transplantation in patients with cirrhosis and hepatocellular carcinoma

(2008) Mauricio Silva et al.   LIVER TRANSPLANTATION

Sorafenib in Advanced Hepatocellular Carcinoma

(2008) Josep M. Llovet et al.   NEW ENGLAND JOURNAL OF MEDICINE

Imaging of Hepatocellular Carcinoma: Qualitative and Quantitative Analysis of Postvascular Phase Contrast-Enhanced Ultrasonography with Sonazoid

(2008) Tatsuo Inoue et al.   ONCOLOGY

Magnetic Resonance Imaging of Hepatocellular Carcinoma Using Contrast Media

(2008) Myeong-Jin Kim et al.   ONCOLOGY

Growth factor receptors and related signalling pathways as targets for novel treatment strategies of hepatocellular cancer

(2008) Michael Höpfner et al.   WORLD JOURNAL OF GASTROENTEROLOGY

The impact of new data in the treatment of advanced hepatocellular carcinoma

(2008) Ghassan K. Abou-Alfa et al.   Current Oncology Reports

Development of sorafenib and other molecularly targeted agents in hepatocellular carcinoma

(2007) Andrew X. Zhu   CANCER

A Novel Prognostic Nomogram Is More Accurate than Conventional Staging Systems for Predicting Survival after Resection of Hepatocellular Carcinoma

(2007) Clifford S. Cho et al.   JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS